These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36854526)

  • 1. Artesunate Exhibits Synergy With Cisplatin and Cytotoxicity for Upper Tract and Bladder Urothelial Carcinoma Cells.
    Chen SY; Chao CN; Huang HY; Zhao PW; Fang CY
    Anticancer Res; 2023 Mar; 43(3):1175-1184. PubMed ID: 36854526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auranofin induces urothelial carcinoma cell death via reactive oxygen species production and synergy with cisplatin.
    Chen SY; Chao CN; Huang HY; Fang CY
    Oncol Lett; 2022 Feb; 23(2):61. PubMed ID: 35069870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction.
    Zhao F; Vakhrusheva O; Markowitsch SD; Slade KS; Tsaur I; Cinatl J; Michaelis M; Efferth T; Haferkamp A; Juengel E
    Cells; 2020 Dec; 9(12):. PubMed ID: 33316936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder.
    Lu CC; Lin MY; Chen SY; Shen CH; Chen LG; Hsieh HY; Chan MW; Hsu CD
    BMC Complement Altern Med; 2013 Feb; 13():44. PubMed ID: 23433042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
    Necchi A; Madison R; Pal SK; Ross JS; Agarwal N; Sonpavde G; Joshi M; Yin M; Miller VA; Grivas P; Chung JH; Ali SM
    Eur Urol Focus; 2021 Nov; 7(6):1339-1346. PubMed ID: 32861617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma.
    Pattarawat P; Hong T; Wallace S; Hu Y; Donnell R; Wang TH; Tsai CL; Wang J; Wang HR
    Br J Cancer; 2020 Jul; 123(2):226-239. PubMed ID: 32390005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells.
    Hsin IL; Wang SC; Li JR; Ciou TC; Wu CH; Wu HM; Ko JL
    Phytomedicine; 2016 Dec; 23(13):1566-1573. PubMed ID: 27823620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells.
    Dyshlovoy SA; Madanchi R; Hauschild J; Otte K; Alsdorf WH; Schumacher U; Kalinin VI; Silchenko AS; Avilov SA; Honecker F; Stonik VA; Bokemeyer C; von Amsberg G
    BMC Cancer; 2017 Feb; 17(1):93. PubMed ID: 28143426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancers.
    Makhlin I; Zhang J; Long CJ; Devarajan K; Zhou Y; Klein-Szanto AJ; Huang M; Chernoff J; Boorjian SA
    BJU Int; 2011 Jul; 108(2 Pt 2):E84-90. PubMed ID: 21050361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder.
    Yang K; Yu W; Liu H; Ding F; Zhang Y; Zhang Y; Wang W; Lou F; Cao S; Wang H; He Z
    Oncologist; 2021 Aug; 26(8):e1395-e1405. PubMed ID: 34050578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage Process.
    Su YL; Xiao LY; Huang SY; Wu CC; Chang LC; Chen YH; Luo HL; Huang CC; Liu TT; Peng JM
    Cells; 2023 May; 12(11):. PubMed ID: 37296592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emetine dihydrochloride: a novel therapy for bladder cancer.
    Foreman KE; Jesse JN; Kuo PC; Gupta GN
    J Urol; 2014 Feb; 191(2):502-9. PubMed ID: 24045224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma.
    Liang PI; Lai HY; Chan TC; Li WM; Hsing CH; Huang SK; Hsieh KL; Tseng WH; Chen TJ; Li WS; Chen HD; Kuo YH; Li CF
    BMC Cancer; 2023 Jun; 23(1):599. PubMed ID: 37380971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.
    Sekino Y; Sakamoto N; Ishikawa A; Honma R; Shigematsu Y; Hayashi T; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
    Oncol Rep; 2019 May; 41(5):3111-3118. PubMed ID: 30864720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex.
    Schlütermann D; Skowron MA; Berleth N; Böhler P; Deitersen J; Stuhldreier F; Wallot-Hieke N; Wu W; Peter C; Hoffmann MJ; Niegisch G; Stork B
    Urol Oncol; 2018 Apr; 36(4):160.e1-160.e13. PubMed ID: 29276062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct mechanisms contribute to acquired cisplatin resistance of urothelial carcinoma cells.
    Höhn A; Krüger K; Skowron MA; Bormann S; Schumacher L; Schulz WA; Hoffmann MJ; Niegisch G; Fritz G
    Oncotarget; 2016 Jul; 7(27):41320-41335. PubMed ID: 27191498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual inhibitor of phosphoinositide 3-kinase/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux.
    Li JR; Cheng CL; Yang CR; Ou YC; Wu MJ; Ko JL
    Toxicol Lett; 2013 Jul; 220(3):267-76. PubMed ID: 23651616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Novel Platinum Analog Dicycloplatin Provides Reliable Growth Inhibition of Urothelial Carcinoma Cells
    Zekan D; Hogan T; Jackson B; Jackson G; Kandzari S
    Anticancer Res; 2024 Aug; 44(8):3243-3254. PubMed ID: 39060036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Primary Tumor Location on Survival from the European Organization for the Research and Treatment of Cancer Advanced Urothelial Cancer Studies.
    Moschini M; Shariat SF; Rouprêt M; De Santis M; Bellmunt J; Sternberg CN; Tombal B; Collette L
    J Urol; 2018 May; 199(5):1149-1157. PubMed ID: 29158104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.